↓ Skip to main content

Treatments for secondary postpartum haemorrhage

Overview of attention for article published in Cochrane database of systematic reviews, January 2002
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (90th percentile)
  • Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

blogs
1 blog
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
70 Dimensions

Readers on

mendeley
195 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Treatments for secondary postpartum haemorrhage
Published in
Cochrane database of systematic reviews, January 2002
DOI 10.1002/14651858.cd002867
Pubmed ID
Authors

Jo Alexander, Peter W Thomas, Jill Sanghera

Abstract

Secondary postpartum haemorrhage is any abnormal or excessive bleeding from the birth canal occurring between 24 hours and 12 weeks postnatally. In developed countries, two per cent of postnatal women are admitted to hospital with this condition, half of them undergoing uterine surgical evacuation; in developing countries it is a major contributor to maternal death. To evaluate the relative effectiveness and safety of the treatments used for secondary postpartum haemorrhage. We searched the Cochrane Pregnancy and Childbirth Group trials register (May 2001), the Cochrane Controlled Trials Register (The Cochrane Library, issue 2, 2001), MEDLINE (back to 1966) and EMBASE (back to 1988). The National Research Register was also searched. The reference lists of trial reports and reviews were searched by hand. Where possible, further sources were sought from the first named authors of the papers identified. All randomised or quasi randomised comparisons between drug therapies, surgical therapies and placebo or no treatment for the management of secondary postpartum haemorrhage occurring between 24 hours and three months following a pregnancy of at least 24 weeks gestation. Reports of possibly eligible studies were scrutinised by two investigators. The third investigator acted as an advisor/arbitrator. Of the 45 papers identified, none met the inclusion criteria. No information is available from randomised controlled trials to inform the management of women with secondary postpartum haemorrhage. This topic may have received little attention because it is perceived as being associated with maternal morbidity rather than mortality in developed countries; it is only recently that the extent and importance of postnatal maternal morbidity has been recognised. A well designed randomised controlled trial comparing the various drug therapies for women with secondary postpartum haemorrhage against each other and against placebo or no treatment groups is needed.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 195 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
India 1 <1%
Ireland 1 <1%
Brazil 1 <1%
Unknown 192 98%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 30 15%
Student > Ph. D. Student 21 11%
Student > Master 18 9%
Researcher 15 8%
Unspecified 13 7%
Other 40 21%
Unknown 58 30%
Readers by discipline Count As %
Medicine and Dentistry 72 37%
Nursing and Health Professions 18 9%
Unspecified 13 7%
Social Sciences 5 3%
Psychology 5 3%
Other 17 9%
Unknown 65 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 December 2021.
All research outputs
#4,331,774
of 25,461,852 outputs
Outputs from Cochrane database of systematic reviews
#6,684
of 12,090 outputs
Outputs of similar age
#12,409
of 133,248 outputs
Outputs of similar age from Cochrane database of systematic reviews
#11
of 37 outputs
Altmetric has tracked 25,461,852 research outputs across all sources so far. Compared to these this one has done well and is in the 82nd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,090 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 38.2. This one is in the 44th percentile – i.e., 44% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 133,248 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 37 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.